Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and Colorectal Cancer Risk

Background Microsomal epoxide hydrolase (EPHX1) plays an important role in both the activation and detoxification of PAHs, which are carcinogens found in cooked meat and tobacco smoking. Polymorphisms at exons 3 and 4 of the EPHX1 gene have been reported to be associated with variations in EPHX1 activity. The aim of this study is to quantitatively summarize the relationship between EPHX1 polymorphisms and colorectal cancer (CRC) risk. Methods Two investigators independently searched the Medline, Embase, CNKI, and Chinese Biomedicine Databases for studies published before June 2012. Summary odds ratios (ORs) and 95% confidence intervals (CIs) for EPHX1 Tyr113His (rs1051740) and His139Arg (rs2234922) polymorphisms and CRC were calculated in a fixed-effects model and a random-effects model when appropriate. Results This meta-analysis yielded 14 case-control studies, which included 13 studies for Tyr113His (6395 cases and 7893 controls) and 13 studies for His139Arg polymorphisms (5375 cases and 6962 controls). Overall, the pooled results indicated that EPHX1 Tyr113His polymorphism was not associated with CRC risk; while the His139Arg polymorphism was significantly associated with decreased CRC risk (Arg/His vs. His/His, OR = 0.90, 95%CI = 0.83–0.98; dominant model, OR = 0.92, 95%CI = 0.85–0.99). The statistically significant association between EPHX1 His139Arg polymorphism and CRC was observed among Caucasians and population-based case-control studies. This association showed little heterogeneity and remained consistently strong when analyses were limited to studies in which genotype frequencies were in Hardy–Weinberg equilibrium, or limited to studies with matched controls. When cumulative meta-analyses of the two associations were conducted by studies’ publication time, the results were persistent and robust. Conclusion This meta-analysis suggests that EPHX1 Tyr113His polymorphism may be not associated with CRC development; while the EPHX1 His139Arg polymorphism may have a potential protective effect on CRC.

[1]  Y. Kakeji,et al.  Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: The Fukuoka Colorectal Cancer Study , 2013, Molecular carcinogenesis.

[2]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[3]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[4]  Liu Liu,et al.  Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case–control studies , 2011, Journal of Cancer Research and Clinical Oncology.

[5]  A. Naccarati,et al.  Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. , 2010, Oncology reports.

[6]  Federica Gemignani,et al.  A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer , 2005, Pharmacogenetics and genomics.

[7]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[8]  C. Smith,et al.  Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer , 1999, British Journal of Cancer.

[9]  Min Dai,et al.  Cancer trends in China. , 2010, Japanese journal of clinical oncology.

[10]  R F Galbraith,et al.  A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.

[11]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[12]  B. Ring,et al.  Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis , 2011, PloS one.

[13]  C. Ulrich,et al.  Microsomal Epoxide Hydrolase Polymorphisms Are Not Associated with Colon Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[14]  D. Harrison,et al.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.

[15]  J. S. Sidhu,et al.  Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. , 1994, Human molecular genetics.

[16]  F. Oesch,et al.  Epoxide hydrolases: structure, function, mechanism, and assay. , 2005, Methods in enzymology.

[17]  P. Dayer,et al.  Association between lung cancer and microsomal epoxide hydrolase genotypes. , 1998, Cancer research.

[18]  T. Wobbes,et al.  Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. , 2006, Mutation research.

[19]  Zhi-jun Chen,et al.  System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk , 2012, Tumor Biology.

[20]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[21]  S. Gallinger,et al.  Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[22]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[23]  J. Barrett,et al.  A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. , 2002, Carcinogenesis.

[24]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[25]  C. J. Omiecinski,et al.  Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. , 1997, Archives of Biochemistry and Biophysics.

[26]  E. Giovannucci,et al.  Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study , 2005, Molecular carcinogenesis.

[27]  Paolo Vineis,et al.  Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. , 2005, Journal of the National Cancer Institute.

[28]  V. Hosagrahara,et al.  Epoxide hydrolase--polymorphism and role in toxicology. , 2000, Toxicology letters.

[29]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[30]  Ammarin Thakkinstian,et al.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. , 2003, Journal of clinical epidemiology.

[31]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[32]  I. Ember,et al.  Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. , 2007, Anticancer research.

[33]  F. Oesch,et al.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[34]  W. Guo,et al.  Epoxide hydrolase Tyr113His polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North China. , 2003, World journal of gastroenterology.

[35]  Hongbing Shen,et al.  Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women , 2006, International journal of cancer.

[36]  L. Le Marchand,et al.  Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. , 2002, Carcinogenesis.

[37]  C. Cacına,et al.  Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society. , 2012, Genetic testing and molecular biomarkers.

[38]  W. Leung,et al.  Increasing incidence of colorectal cancer in Asia: implications for screening. , 2005, The Lancet. Oncology.

[39]  G. Hoff,et al.  Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas , 2007, BMC Cancer.

[40]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[41]  S. Gallinger,et al.  Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. , 2010, American journal of epidemiology.

[42]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.